skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:015732/0696   Pages: 50
Recorded: 08/25/2004
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 17
1
Patent #:
Issue Dt:
05/09/1989
Application #:
06697078
Filing Dt:
01/31/1985
Title:
TUMOR SPECIFIC MONOCLONAL ANTIBODIES
2
Patent #:
Issue Dt:
04/21/1992
Application #:
07302155
Filing Dt:
01/25/1989
Title:
TUMOR SPECIFIC MONOCLONAL ANTIBODIES
3
Patent #:
Issue Dt:
01/21/1992
Application #:
07350879
Filing Dt:
05/11/1989
Title:
LEUKOREGULIN, AN ANTITUMOR LYMPHOKINE, AND ITS THERAPEUTIC USES
4
Patent #:
Issue Dt:
01/19/1993
Application #:
07645069
Filing Dt:
01/22/1991
Title:
TUMOR SPECIFIC MONOCLONAL ANTIBODIES
5
Patent #:
Issue Dt:
08/16/1994
Application #:
07929842
Filing Dt:
08/13/1992
Title:
ANTIGEN RECOGNIZED BY MCA 16-88
6
Patent #:
Issue Dt:
05/28/1996
Application #:
08041529
Filing Dt:
04/01/1993
Title:
CTAA 28A32, THE ANTIGEN RECOGNIZED BY MCA 28A32
7
Patent #:
Issue Dt:
03/08/1994
Application #:
08044875
Filing Dt:
04/08/1993
Title:
CHELATING AGENTS FOR ATTACHING METAL IONS TO PROTEINS
8
Patent #:
Issue Dt:
04/18/1995
Application #:
08050697
Filing Dt:
04/19/1993
Title:
METHOD OF TREATING BLADDER CANCER WITH A KEYHOLE LIMPET HEMOCYANIN COMPOSTION WITH ENHANCED ANTI-TUMOR
9
Patent #:
Issue Dt:
09/20/1994
Application #:
08094589
Filing Dt:
07/20/1993
Title:
TUMOR ASSOCIATED MONOCLONAL ANTIBODY 81AV78
10
Patent #:
Issue Dt:
01/16/1996
Application #:
08122257
Filing Dt:
11/01/1993
Title:
ACTIVE SPECIFIC IMMONOTHERAPY
11
Patent #:
Issue Dt:
11/26/1996
Application #:
08140186
Filing Dt:
11/04/1993
Title:
IN VIVO BINDING PAIR PRETARGETING
12
Patent #:
Issue Dt:
12/12/1995
Application #:
08449613
Filing Dt:
05/24/1995
Title:
TUMOR ASSOCIATED MONOCLONAL ANTIBODIES
13
Patent #:
Issue Dt:
01/05/1999
Application #:
08837498
Filing Dt:
03/26/1997
Title:
METHOD USING KEYHOLE LIMPET HEMOCYANIN COMPOSITION WITH ENHANCED IM- MUNOGENIC
14
Patent #:
Issue Dt:
09/14/1999
Application #:
08960128
Filing Dt:
08/19/1997
Title:
TUMOR ASSOCIATED EPITOPE
15
Patent #:
Issue Dt:
11/09/1999
Application #:
09009121
Filing Dt:
01/20/1998
Title:
KEYHOLE LIMPET HEMOCYANIN COMPOSITION WITH ENHANCED IMMUNOGENIC ACTIVITY
16
Patent #:
Issue Dt:
12/08/2009
Application #:
10370081
Filing Dt:
02/21/2003
Publication #:
Pub Dt:
12/11/2003
Title:
STERILE IMMUNOGENIC NON-TUMORIGENIC TUMOR CELL COMPOSITIONS AND METHODS
17
Patent #:
Issue Dt:
02/10/2009
Application #:
10425855
Filing Dt:
04/30/2003
Publication #:
Pub Dt:
01/08/2004
Title:
NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS
Assignors
1
Exec Dt:
05/27/2004
2
Exec Dt:
05/27/2004
3
Exec Dt:
05/27/2004
4
Exec Dt:
05/27/2004
5
Exec Dt:
05/27/2004
6
Exec Dt:
05/27/2004
7
Exec Dt:
05/27/2004
8
Exec Dt:
05/27/2004
9
Exec Dt:
05/27/2004
Assignees
1
NASSI GROUP, LLC ATTENTION: DANIEL KANE 340 N. WESTLAKE BOULEVARD, SUITE 340
WESTLAKE VILLAGE, CALIFORNIA 91362
2
13888 TRINITY AVENUE
SARATOGA, CALIFORNIA 95070-5339
3
13888 TRINITY AVENUE
SARATOGA, CALIFORNIA 95070-5339
4
62 CLAPBOARD RIDGE ROAD
GREENWICH, CONNECTICUT 06830
5
720 SOUTH OCEAN BOULEVARD
PALM BEACH, FLORIDA 33480
6
111 HUNTINGTON AVENUE
BOSTON, MASSACHUSETTS 02199
7
111 HUNTINGTON AVENUE
BOSTON, MASSACHUSETTS 02199
8
111 HUNTINGTON AVENUE
BOSTON, MASSACHUSETTS 02199
9
111 HUNTINGTON AVENUE
BOSTON, MASSACHUSETTS 02199
10
111 HUNTINGTON AVENUE
BOSTON, MASSACHUSETTS 02199
Correspondence name and address
MINTZ LEVIN ET AL.
FLORA W. FENG
666 THIRD AVENUE, 24TH FLOOR
NEW YORK, NY 10017

Search Results as of: 09/22/2024 02:51 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT